PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells

• Published in: Carcinogenesis (New York) Vol. 26; no. 8; pp. 1374 - 1381
• Main Authors: Hu, Hongbo, Jiang, Cheng, Li, Guangxun, Lü, Junxuan
• Format: Journal Article
• Language: English
• Published: Oxford Oxford University Press 01.08.2005; Oxford Publishing Limited (England)
• Subjects: Apoptosis - drug effects; Biological and medical sciences; Butadienes - pharmacology; Carcinogenesis, carcinogens and anticarcinogens; Caspases - metabolism; Cell Line, Tumor; Chromones - pharmacology; ERK; extracellular signal regulated kinase; glycogen synthase kinase-3; GSK-3; Humans; Kinetics; Male; Medical sciences; methylseleninic acid; Mitogen-Activated Protein Kinases - metabolism; Morpholines - pharmacology; MSeA; Nitriles - pharmacology; Organoselenium Compounds - pharmacology; PARP; PCa; phosphatase and tensin homologue deleted on chromosome 10; phosphatidylinositol 3-kinase; Phosphorylation; PI3K; poly(ADP-ribose) polymerase; prostate cancer; Prostatic Neoplasms; Protein-Serine-Threonine Kinases - metabolism; Proto-Oncogene Proteins - metabolism; Proto-Oncogene Proteins c-akt; PTEN; Tumors; Urinary system disease; Protein kinase B; Prostate disease; Extracellular signal-regulated protein kinase; Enzyme; Cysteine endopeptidases; Caspase; Mitogen-activated protein kinase; Malignant tumor; Peptidases; Regulation(control); Cell death; Established cell line; Hydrolases; Male genital diseases; Prostate cancer; Tumor cell; Apoptosis
• ISSN: 0143-3334; 1460-2180
• DOI: 10.1093/carcin/bgi094

Methylselenol has been implicated as an active metabolite for the anticancer effect of selenium in part through the induction of cancer cell apoptosis. Since inactivation of the AKT/protein kinase B negative regulator gene PTEN (phosphatase and tensin homologue deleted on chromosome 10) is common in prostate cancer (PCa), we compared PTEN wild-type DU145 PCa cells (low basal AKT activity) with PTEN-mutant LNCaP PCa cells (high basal AKT activity) for their apoptosis responses to the methylselenol precursor methylseleninic acid (MSeA) and sodium selenite, an inorganic salt. Our results show that LNCaP cells withstood ∼4 times higher doses of MSeA than DU145 cells, although they were slightly more sensitive than the latter to selenite-induced apoptosis. Treatment by MSeA modestly attenuated AKT phosphorylation and increased phospho-ERK1/2 in LNCaP cells. Selenite treatment increased the phosphorylation of p53 Ser15 and both kinases, but the selenite-induced apoptosis was not influenced by chemical inhibitors of either kinase. In contrast, PI3K/AKT inhibitors greatly sensitized LNCaP cells to apoptosis induced by MSeA, accompanied by increased mitochondrial release of cytochrome c and multiple caspase activation without changing p53 Ser15 phosphorylation. The apoptosis was further accentuated by extracellular signal regulated kinases 1 and 2 (ERK1/2) inhibition without further increase in cytochrome c release. The general caspase inhibitor z-VAD-fmk completely blocked MSeA-induced apoptosis when both kinases were inhibited, whereas a caspase-8 inhibitor exerted a greater protection than did a caspase-9 inhibitor. Transfection of DU145 cells with a constitutively active AKT increased their resistance to MSeA-induced apoptosis. In summary, AKT played an important role in regulating apoptosis sensitivity of LNCaP and DU145 cells to MSeA. An MSeA-induced activation of ERK1/2 in LNCaP cells also contributed to resistance to apoptosis. However, these kinases did not significantly regulate caspase-mediated apoptosis induced by selenite in LNCaP cells. These findings support the differential involvement of these protein kinase pathways in regulating apoptosis induction by different forms of selenium.